Pilot Study of PHOENIX Wound Matrix® Impact on Chronic DFU Wound Microbiome
A Pilot Study to Assess the Impact of PHOENIX Wound Matrix® on the Wound Microbiome in Chronic Diabetic Foot Ulcers
Sponsor: Lindsay Kalan PhD, Kalan Lab, McMaster University
This NA trial investigates Diabetic Foot Ulcer and is currently completed. Lindsay Kalan PhD, Kalan Lab, McMaster University leads this study, which shows 11 recorded versions since 2025 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2025 — Feb 2026 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Not Yet Recruiting NA
Status: Unknown → Not Yet Recruiting · Phase: None → NA
-
Sep 2024 — Feb 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
▶ Show 6 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Dec 2021 — Nov 2023 [monthly]
Not Yet Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Lindsay Kalan PhD, Kalan Lab, McMaster University
- RenovoDerm
- Simon Tabchi DPM, PA Foot & Ankle Associates
For direct contact, visit the study record on ClinicalTrials.gov .